About Joshua Korzenik
Form D filings for Bilayer Therapeutics from 2021 to 2023 list Joshua Korzenik as director.
Joshua Korzenik first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Joshua Korzenik in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joshua Korzenik works with at each company, as listed on that company's latest Form D.
Bilayer Therapeutics, Inc. · Form D, Aug 4, 2023
TC
Thomas Collet
President and director
RL
Robert Langer
Director
HC
Huang Yen-Chen
Director
DZ
David Zhu
Director
CT
Carlo Traverso
Director